Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

UNKNOWN × Carcinoma, Non-Small-Cell Lung × Sunitinib × Clear all

Phase

Status

Sponsor Class

INDUSTRY 10 OTHER 7 NIH 2 UNKNOWN 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasms 1 Lung Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

icotinib 2 Erlotinib Hydrochloride 2 camrelizumab 1 aumolertinib 1 apatinib 1 Sunitinib 1 Radiotherapy, Intensity-Modulated 1 Radiosurgery 1 Radiation 1 Pemetrexed 1 Gemcitabine 1 Gefitinib 1 Drug Therapy 1 Cisplatin 1 Chemoradiotherapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01850147 2013-05-09

Sequential Use of Low-dose Sunitinib With Chemotherapy in Advanced NSCLC After Failure of Conventional Regimen

ChineseAMS

Phase 2 Unknown

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡